These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 19187868

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antiviral therapy for chronic hepatitis B.
    Jafri SM, Lok AS.
    Clin Liver Dis; 2010 Aug; 14(3):425-38. PubMed ID: 20638023
    [Abstract] [Full Text] [Related]

  • 5. Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.
    Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI.
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1374-80. PubMed ID: 20659226
    [Abstract] [Full Text] [Related]

  • 6. Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues.
    Leung N.
    Liver Int; 2011 Jan; 31 Suppl 1():85-9. PubMed ID: 21205143
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
    Boni C, Laccabue D, Lampertico P, Giuberti T, Viganò M, Schivazappa S, Alfieri A, Pesci M, Gaeta GB, Brancaccio G, Colombo M, Missale G, Ferrari C.
    Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir.
    Kwak MS, Choi JW, Lee JS, Kim KA, Suh JH, Cho YS, Won SY, Park BK, Lee CK.
    J Viral Hepat; 2011 Oct; 18(10):e432-8. PubMed ID: 21914060
    [Abstract] [Full Text] [Related]

  • 10. [A study on the treatment of chronic hepatitis B with YMDD mutation].
    Qiu YW, Jiang XH, Huang LH, Hu TH, Ding H, Jiang YM, Dai YX, Zhou M.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):171-4. PubMed ID: 19335977
    [Abstract] [Full Text] [Related]

  • 11. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
    Buster EH, Schalm SW, Janssen HL.
    Best Pract Res Clin Gastroenterol; 2008 Mar; 22(6):1093-108. PubMed ID: 19187869
    [Abstract] [Full Text] [Related]

  • 12. On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.
    Chien RN.
    J Gastroenterol Hepatol; 2010 May; 25(5):852-7. PubMed ID: 20546437
    [Abstract] [Full Text] [Related]

  • 13. Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.
    Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL.
    Gastroenterology; 2010 Aug; 139(2):491-8. PubMed ID: 20381492
    [Abstract] [Full Text] [Related]

  • 14. Telbivudine in the treatment of chronic hepatitis B.
    Nash K.
    Adv Ther; 2009 Feb; 26(2):155-69. PubMed ID: 19225726
    [Abstract] [Full Text] [Related]

  • 15. [Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].
    Buti M.
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():32-8. PubMed ID: 19100229
    [Abstract] [Full Text] [Related]

  • 16. [Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B].
    Zhou HJ, Li SG, Wen FY, Yang XY, Wu JL, Tan B, Fu J.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):564-8. PubMed ID: 19719911
    [Abstract] [Full Text] [Related]

  • 17. Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis.
    Choe WH, Kwon SY, Kim BK, Ko SY, Yeon JE, Byun KS, Kim GH, Lee CH.
    Liver Int; 2008 Jul; 28(6):814-20. PubMed ID: 18312291
    [Abstract] [Full Text] [Related]

  • 18. Treatment of chronic hepatitis B: Evolution over two decades.
    Yuen MF, Lai CL.
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
    [Abstract] [Full Text] [Related]

  • 19. The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.
    Lampertico P, Invernizzi F, Viganò M, Loglio A, Mangia G, Facchetti F, Primignani M, Jovani M, Iavarone M, Fraquelli M, Casazza G, de Franchis R, Colombo M.
    J Hepatol; 2015 Nov; 63(5):1118-25. PubMed ID: 26100495
    [Abstract] [Full Text] [Related]

  • 20. Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues.
    Rodriguez-Frias F, Jardi R, Schaper M, Gimferrer M, Elefsiniotis I, Tabernero D, Esteban R, Buti M.
    J Med Virol; 2007 Nov; 79(11):1671-3. PubMed ID: 17854030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.